Samsung Biologics207940
Samsung Biologics (207940) Insider Ownership Report, Nov 4, 2026
Filing date ·
Je Im-seu-choe, an executive of Samsung Biologics (Executive Vice President), reported a decrease of 25 shares in holdings of Samsung Biologics stock.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.